TP53 and cervical squamous intraepithelial neoplasia: For CIN tumors at early stage (Fig. 7a), the APC, KRAS, and TP53 mutations and arm-level copy losses occur one after another, and the dominant clones carry all of these driver alterations—so the linear model is in action at early stage.